Encephalopathy Acute Infection Induced Susceptibility To 9 C5193089
Brain dysfunction linked to increased susceptibility to HHV-9 infection. Can cause various neurological symptoms. Treatment requires addressing underlying infection with supportive care.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Motor weakness
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Varies
Lethargy
(neurologic)Behavioral changes
(neurologic)Sensory disturbances
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Empiric antimicrobial therapy
Broad-spectrum antibiotics and potentially antiviral agents initiated immediately upon suspicion of infectious encephalopathy, adjusted based on diagnostic findings and clinical response. Early treatment is critical for optimal outcomes.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Critical care management
Aggressive supportive care in an intensive care setting including airway management, hemodynamic support, and prevention of secondary complications such as pneumonia and deep vein thrombosis.
Additional treatment options
Immunomodulatory therapy
Intravenous immunoglobulin or other immunomodulatory agents may be considered in cases where immune-mediated mechanisms contribute to encephalopathy, particularly when standard antimicrobial therapy is insufficient.
medicationLumbar puncture for diagnosis
Cerebrospinal fluid analysis to identify causative pathogens, measure opening pressure, and guide ongoing treatment decisions. May need to be repeated if clinical deterioration occurs.
procedureNutritional support
Adequate caloric and nutritional support through enteral or parenteral routes to maintain metabolic demands during critical illness and support neurological recovery.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Encephalopathy Acute Infection Induced Susceptibility To 9 C5193089?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Encephalopathy Acute Infection Induced Susceptibility To 9 C5193089. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy